THE VACCINE MAKER MODERNA decided this past week to tell the world about bad news it had received from the federal government. A potentially groundbreaking vaccine for seasonal flu that the Massachusetts-based company had developed would not be getting approval from regulators.

The pharmaceutical industry is not the enemy,” writes Richard Hughes IV, who was Moderna’s VP for public policy when the Covid vaccine rolled out.

Flu vaccination rates among U.S. adults have fallen 24% since 2020, putting this season on track for a seven-year low. Many Americans say they skip

Last month, cases of flu reached their highest levels in the United States in 25 years. Many hospitals were unprepared for the surge; as emergency wards filled with flu patients, healthcare workers were left to weather the impacts.

Research head says assessment was reassuring as it revealed jab still offered worthwhile protection despite being a mismatch for the dominant strain

Influenza A viruses are responsible for most flu outbreaks and severe cases, while influenza B viruses also contribute significantly, particularly among children. Each year, the influenza vaccine is updated based on the strains selected through global surveillance to match the viruses most likely to circulate during the upcoming flu season.